{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:48:29Z","timestamp":1792813709750,"version":"4.5.0"},"reference-count":163,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 EY09171-14"],"award-info":[{"award-number":["R01 EY09171-14"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["NIH R01 EY10659-12"],"award-info":[{"award-number":["NIH R01 EY10659-12"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jconrel.2017.01.012","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T09:33:22Z","timestamp":1484127202000},"page":"96-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":460,"special_numbering":"C","title":["Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies"],"prefix":"10.1016","volume":"248","author":[{"given":"Abhirup","family":"Mandal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2596-4028","authenticated-orcid":false,"given":"Rohit","family":"Bisht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5997-5994","authenticated-orcid":false,"given":"Ilva D.","family":"Rupenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashim K.","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.01.012_bb0005","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.drudis.2007.10.021","article-title":"Nanotechnology in ocular drug delivery","volume":"13","author":"Sahoo","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0010","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1021\/nn4015399","article-title":"Design principles for clinical efficacy of cancer nanomedicine: a look into the basics","volume":"7","author":"Sengupta","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","article-title":"Drug delivery and nanoparticles: applications and hazards","volume":"3","author":"De Jong","year":"2008","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0020","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1167\/iovs.10-5392","article-title":"Ophthalmic Drug Delivery Systems for the treatment of retinal diseases: basic research to clinical applications","volume":"51","author":"Edelhauser","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2017.01.012_bb0025","article-title":"Are animal models predictive for humans?","volume":"4","author":"Shanks","year":"2009","journal-title":"Philos. Ethics Humanit. Med.: PEHM"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/OPTH.S1067","article-title":"Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension","volume":"2","author":"Gaynes","year":"2008","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0035","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1089\/hum.2011.090","article-title":"Persistent suppression of ocular neovascularization with intravitreal administration of AAVrh.10 coding for Bevacizumab","volume":"22","author":"Mao","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00347-003-0975-z","article-title":"Ocular side effects and complications of intravitreal triamcinolone acetonide injection","volume":"101","author":"Jaissle","year":"2004","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0045","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2147\/OPTH.S4033","article-title":"Cystoid macular edema","volume":"2","author":"Rotsos","year":"2008","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0050","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/aps.2010.98","article-title":"Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability","volume":"31","author":"Han","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1208\/s12248-008-9024-9","article-title":"Topical ocular delivery of NSAIDs","volume":"10","author":"Ahuja","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/0975-7406.67003","article-title":"Cyclodextrins in delivery systems: applications","volume":"2","author":"Tiwari","year":"2010","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1081\/DDC-120003445","article-title":"Ocular preparations: the formulation approach","volume":"28","author":"Kaur","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nantod.2015.01.005","article-title":"Core-crosslinked polymeric micelles: principles, preparation, biomedical applications and clinical translation","volume":"10","author":"Talelli","year":"2015","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0075","doi-asserted-by":"crossref","first-page":"164692","DOI":"10.1155\/2014\/164692","article-title":"Sustained-release corticosteroid options","volume":"2014","author":"Cabrera","year":"2014","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0080","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2012.08.042","article-title":"Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs","volume":"453","author":"Lu","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.2042-7158.1980.tb12947.x","article-title":"Effects of structural variations of non-ionic surfactants on micellar properties and solubilization: surfactants based on erucyl and behenyl (C22) alcohols","volume":"32","author":"Arnarson","year":"1980","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2217\/nnm.10.10","article-title":"Nanomicellar formulations for sustained drug delivery: strategies and underlying principles","volume":"5","author":"Trivedi","year":"2010","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0095","doi-asserted-by":"crossref","first-page":"951741","DOI":"10.1155\/2012\/951741","article-title":"A versatile polymer micelle drug delivery system for encapsulation and in vivo stabilization of hydrophobic anticancer drugs","volume":"2012","author":"Rios-Doria","year":"2012","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: an overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2004.07.001","article-title":"Model of transient drug diffusion across cornea","volume":"99","author":"Zhang","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0115","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.eye.6700566","article-title":"Tears in health and disease","volume":"17","author":"Tiffany","year":"2003","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0120","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/17425255.2011.562195","article-title":"In vitro cell culture models to study the corneal drug absorption","volume":"7","author":"Reichl","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0125","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0130","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.addr.2006.07.024","article-title":"Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics","volume":"58","author":"Mannermaa","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0378-5173(92)90309-P","article-title":"The effect of polyethylene-glycol molecular-weight on corneal transport and the related influence of penetration enhancers","volume":"88","author":"Liaw","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0140","first-page":"238","article-title":"Ocular drug delivery; impact of in vitro cell culture models","volume":"4","author":"Barar","year":"2009","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0145","first-page":"627","article-title":"Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera","volume":"38","author":"Hamalainen","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0150","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2014.06.043","article-title":"Ocular delivery of macromolecules","volume":"190","author":"Kim","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0155","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1124\/dmd.116.069369","article-title":"Drug transport by the blood-aqueous humor barrier of the eye","volume":"44","author":"Lee","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0160","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0039-6257(79)90158-9","article-title":"The blood-ocular barriers","volume":"23","author":"Cunha-Vaz","year":"1979","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0165","first-page":"59","article-title":"Use of ionizing radiation in transplantation","volume":"6","author":"van Bekkum","year":"1974","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/17425247.1.1.99","article-title":"Periocular routes for retinal drug delivery","volume":"1","author":"Raghava","year":"2004","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0175","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1517\/17425247.2016.1163334","article-title":"Light-responsive in situ forming injectable implants for effective drug delivery to the posterior segment of the eye","volume":"13","author":"Bisht","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0180","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1517\/17425247.2014.935338","article-title":"Advances in ocular drug delivery: emphasis on the posterior segment","volume":"11","author":"Kang-Mieler","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0185","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","article-title":"Topical and systemic drug delivery to the posterior segments","volume":"57","author":"Hughes","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jop.1986.2.67","article-title":"Topical ocular drug delivery: recent developments and future challenges","volume":"2","author":"Lee","year":"1986","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpb.2012.02.014","article-title":"Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies","volume":"81","author":"Di Tommaso","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0200","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1021\/bc025524y","article-title":"Cellular internalization of poly(ethylene oxide)-b-poly(epsilon-caprolactone) diblock copolymer micelles","volume":"13","author":"Luo","year":"2002","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0205","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0005-2736(99)00108-X","article-title":"Cellular internalization of PCL(20)-b-PEO(44) block copolymer micelles","volume":"1421","author":"Allen","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0210","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1126\/science.1078192","article-title":"Micellar nanocontainers distribute to defined cytoplasmic organelles","volume":"300","author":"Savic","year":"2003","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0215","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.2147\/IJN.S90347","article-title":"Positively charged micelles based on a triblock copolymer demonstrate enhanced corneal penetration","volume":"10","author":"Li","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1872211308666140130093301","article-title":"Drug delivery to the back of the eye following topical administration: an update on research and patenting activity","volume":"8","author":"Boddu","year":"2014","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0225","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.drudis.2010.12.004","article-title":"Drug delivery to the posterior segment of the eye","volume":"16","author":"Thrimawithana","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0230","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1877912311202020082","article-title":"Novel nanomicellar formulation approaches for anterior and posterior segment ocular drug delivery","volume":"2","author":"Cholkar","year":"2012","journal-title":"Recent Pat. Nanomed."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0235","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mabi.201100419","article-title":"Nanomaterials for ocular drug delivery","volume":"12","author":"Liu","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0240","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11095-015-1784-1","article-title":"Polymeric micelles: recent advancements in the delivery of anticancer drugs","volume":"33","author":"Gothwal","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0245","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jconrel.2014.06.042","article-title":"Progress of drug-loaded polymeric micelles into clinical studies","volume":"190","author":"Cabral","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0250","series-title":"Applied Surfactants","first-page":"309","article-title":"Microemulsions","author":"Tadros","year":"2005"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0255","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1517\/17425247.3.1.139","article-title":"Polymeric micelles for drug delivery","volume":"3","author":"Aliabadi","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nantod.2012.01.002","article-title":"Polymeric micelle stability","volume":"7","author":"Owen","year":"2012","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0265","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-3659(01)00299-1","article-title":"Structure and design of polymeric surfactant-based drug delivery systems","volume":"73","author":"Torchilin","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0270","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.nantod.2012.08.005","article-title":"Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: promises, progress and prospects","volume":"7","author":"Deng","year":"2012","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0275","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0169-409X(96)00401-2","article-title":"Polymeric micelles as new drug carriers","volume":"21","author":"Kwon","year":"1996","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0280","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.nano.2010.05.005","article-title":"Advances in polymeric micelles for drug delivery and tumor targeting","volume":"6","author":"Kedar","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0285","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/jps.10397","article-title":"Amphiphilic block copolymers for drug delivery","volume":"92","author":"Adams","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0290","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.biomaterials.2008.09.010","article-title":"Drug releasing behavior of hybrid micelles containing polypeptide triblock copolymer","volume":"30","author":"Lin","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0295","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1039\/c0py00406e","article-title":"Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure-property relationships to better defined therapeutics","volume":"2","author":"Barz","year":"2011","journal-title":"Polym. Chem.-UK"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0300","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1021\/mz300285x","article-title":"Molecular exchange in diblock copolymer micelles: bimodal distribution in Core-block molecular weights","volume":"1","author":"Lu","year":"2012","journal-title":"ACS Macro Lett."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0305","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3109\/1061186X.2014.934688","article-title":"Polymeric micelles as drug carriers: their lights and shadows","volume":"22","author":"Yokoyama","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0939-6411(99)00039-9","article-title":"Polymeric micelles - a new generation of colloidal drug carriers","volume":"48","author":"Jones","year":"1999","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0315","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0168-3659(93)90172-2","article-title":"Block copolymer micelles as vehicles for drug delivery","volume":"24","author":"Kazunori","year":"1993","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0320","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0169-409X(01)00222-8","article-title":"Advanced drug delivery devices via self-assembly of amphiphilic block copolymers","volume":"53","author":"Rosler","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0325","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2006.01.010","article-title":"Thermo-sensitive transition of monomethoxy poly(ethylene glycol)-block-poly(trimethylene carbonate) films to micellar-like nanoparticles","volume":"112","author":"Zhang","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0330","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/jps.2600840904","article-title":"New synthetic amphiphilic polymers for steric protection of liposomes in vivo","volume":"84","author":"Torchilin","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0335","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1021\/la010246x","article-title":"Hybrid polymeric micelles with hydrophobic cores and mixed polyelectrolyte\/nonelectrolyte shells in aqueous media. 1. Preparation and basic characterization","volume":"17","author":"\u0160t\u011bp\u00e1nek","year":"2001","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0340","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1023\/A:1007529218802","article-title":"Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide). Part I: effects of the level of methotrexate conjugation on the stability of micelles and on drug release","volume":"17","author":"Li","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0345","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.molliq.2014.09.021","article-title":"Role of Pluronic F127 micelles in enhancing ocular delivery of ciprofloxacin","volume":"199","author":"Taha","year":"2014","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0350","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.colsurfb.2015.03.059","article-title":"Zero order delivery of itraconazole via polymeric micelles incorporated in situ ocular gel for the management of fungal keratitis","volume":"130","author":"Jaiswal","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0355","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.colsurfb.2013.06.047","article-title":"Ocular biocompatibility and tolerance study of biodegradable polymeric micelles in the rabbit eye","volume":"112","author":"Xu","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0360","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijpharm.2016.06.013","article-title":"Lenghty reverse poly(butylene oxide)-poly(ethylene oxide)-poly(butylene oxide) polymeric micelles and gels for sustained release of antifungal drugs","volume":"510","author":"Figueroa-Ochoa","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0365","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2009.05.028","article-title":"Polyhydroxyethylaspartamide-based micelles for ocular drug delivery","volume":"378","author":"Civiale","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0370","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jps.23390","article-title":"Hydrogel containing silica shell cross-linked micelles for ocular drug delivery","volume":"102","author":"Lu","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0375","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/j.xphs.2016.02.014","article-title":"Self-assembled thermoresponsive nanogels prepared by reverse micelle \u2013>Positive micelle method for ophthalmic delivery of muscone, a poorly water-soluble drug","volume":"105","author":"Wang","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0380","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejpb.2014.12.010","article-title":"Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery system","volume":"89","author":"Ma","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0385","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijpharm.2011.01.004","article-title":"Ocular biocompatibility of novel cyclosporin a formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers","volume":"416","author":"Di Tommaso","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0390","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.colsurfb.2015.02.007","article-title":"Novel in situ gel systems based on P123\/TPGS mixed micelles and gellan gum for ophthalmic delivery of curcumin","volume":"128","author":"Duan","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00508-1","article-title":"Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies","volume":"209","author":"Gupta","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0400","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijpharm.2015.07.010","article-title":"Tri\/tetra-block co-polymeric nanocarriers as a potential ocular delivery system of lornoxicam: in-vitro characterization, and in-vivo estimation of corneal permeation","volume":"492","author":"Salama","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0405","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.colsurfb.2012.10.055","article-title":"Poloxamine micellar solubilization of alpha-tocopherol for topical ocular treatment","volume":"103","author":"Ribeiro","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0410","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.colsurfb.2009.03.027","article-title":"Solubilization of poorly water-soluble drug carbamezapine in pluronic micelles: effect of molecular characteristics, temperature and added salt on the solubilizing capacity","volume":"72","author":"Kadam","year":"2009","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0415","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1002\/jps.22137","article-title":"A nonionic surfactant\/chitosan micelle system in an innovative eye drop formulation","volume":"99","author":"Pepic","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0420","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/jps.23370","article-title":"Influence of drug lipophilicity on drug release from sclera after iontophoretic delivery of mixed micellar carrier system to human sclera","volume":"102","author":"Chopra","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0425","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.colsurfb.2015.12.053","article-title":"Micellar delivery of dasatinib for the inhibition of pathologic cellular processes of the retinal pigment epithelium","volume":"140","author":"Li","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0430","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2010.06.006","article-title":"Polymeric micelle gene delivery of bcl-xL via eye drop reduced corneal apoptosis following epithelial debridement","volume":"147","author":"Tong","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0435","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0168-3659(94)90118-X","article-title":"Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly (ethylene oxide-aspartate) block copolymer-adriamycin conjugates","volume":"29","author":"Kwon","year":"1994","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0440","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0168-3659(94)90153-8","article-title":"Influencing factors on in vitro micelle stability of adriamycin-block copolymer conjugates","volume":"28","author":"Masayuki","year":"1994","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0445","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1023\/A:1018998203127","article-title":"Biodistribution of micelle-forming polymer-drug conjugates","volume":"10","author":"Kwon","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0450","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1023\/A:1018921513605","article-title":"Analysis of micelle formation of an adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer by gel permeation chromatography","volume":"10","author":"Yokoyama","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0455","first-page":"1693","article-title":"Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer","volume":"50","author":"Yokoyama","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0460","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/17425240903436479","article-title":"Polymeric micelles as a new drug carrier system and their required considerations for clinical trials","volume":"7","author":"Yokoyama","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0465","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0168-3659(98)00149-7","article-title":"Micellar delivery of doxorubicin and its paramagnetic analog, ruboxyl, to HL-60 cells: effect of micelle structure and ultrasound on the intracellular drug uptake","volume":"58","author":"Rapoport","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0470","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4155\/bio.14.71","article-title":"Reasons for calibration standard curve slope variation in LC\u2013MS assays and how to address it","volume":"6","author":"Zhao","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0475","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1023\/A:1016266523505","article-title":"Physical entrapment of adriamycin in AB block copolymer micelles","volume":"12","author":"Kwon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0480","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-3659(97)00245-9","article-title":"Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B","volume":"53","author":"Yu","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0485","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/1097-4636(20001215)52:4<831::AID-JBM29>3.0.CO;2-K","article-title":"Micelles of poly(ethylene oxide)-block-poly(N-alkyl stearate L-aspartamide): synthetic analogues of lipoproteins for drug delivery","volume":"52","author":"Lavasanifar","year":"2000","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0490","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1007\/s11095-005-7781-z","article-title":"Comparison of diafiltration and tangential flow filtration for purification of nanoparticle suspensions","volume":"22","author":"Dalwadi","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0495","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/js950204r","article-title":"Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl l-aspartate) block copolymer micelles","volume":"85","author":"La","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0500","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-3659(99)00133-9","article-title":"Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance","volume":"64","author":"Kataoka","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/ps050426","article-title":"Amphiphilic star-like macromolecules as novel carriers for topical delivery of nonsteroidal anti-inflammatory drugs","volume":"5","author":"Djordjevic","year":"2003","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0510","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-3659(01)00537-5","article-title":"The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly(ethylene oxide)-block-poly(N-hexyl stearate-l-aspartamide)","volume":"79","author":"Lavasanifar","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0515","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s002800050630","article-title":"An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel","volume":"40","author":"Zhang","year":"1997","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0520","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0378-5173(95)04386-1","article-title":"Development of amphiphilic diblock copolymers as micellar carriers of taxol","volume":"132","author":"Zhang","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0525","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1021\/bc034113u","article-title":"Core-cross-linked polymeric micelles as paclitaxel carriers","volume":"15","author":"Shuai","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0530","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jconrel.2004.06.003","article-title":"Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery","volume":"98","author":"Shuai","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0535","doi-asserted-by":"crossref","DOI":"10.1002\/app.42555","article-title":"Preparation and characterization of mPEG-g-\u03b1-zein biohybrid micelles as a nano-carrier","volume":"132","author":"Song","year":"2015","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0540","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1023\/B:PHAM.0000033005.25698.9c","article-title":"Preparation and drug loading of poly(ethylene glycol)-block-poly(epsilon-caprolactone) micelles through the evaporation of a cosolvent azeotrope","volume":"21","author":"Jette","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0545","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jconrel.2004.06.018","article-title":"Poly(N-vinylpyrrolidone)-block-poly(D,l-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation","volume":"99","author":"Le Garrec","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0550","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/la980572l","article-title":"Preparation and characterization of self-assembled polymer\u2013metal complex micelle from cis-dichlorodiammineplatinum(II) and poly(ethylene glycol)\u2013Poly(\u03b1,\u03b2-aspartic acid) block copolymer in an aqueous medium","volume":"15","author":"Nishiyama","year":"1999","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0555","first-page":"8977","article-title":"Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice","volume":"63","author":"Nishiyama","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0560","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1021\/la0488811","article-title":"Stabilization of lysozyme-incorporated polyion complex micelles by the omega-end derivatization of poly(ethylene glycol)-poly(alpha,beta-aspartic acid) block copolymers with hydrophobic groups","volume":"21","author":"Yuan","year":"2005","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0565","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1021\/bm040009j","article-title":"Polyion complex micelles of pDNA with Acetal-poly(ethylene glycol)-poly(2-(dimethylamino)ethyl methacrylate) block copolymer as the Gene carrier system: physicochemical properties of micelles relevant to Gene transfection efficacy","volume":"5","author":"Wakebayashi","year":"2004","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0570","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1021\/bc025555t","article-title":"Differential gene expression profile between PC-14 cells treated with free cisplatin and cisplatin-incorporated polymeric micelles","volume":"14","author":"Nishiyama","year":"2003","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0575","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1021\/ac034346e","article-title":"A core-shell-type fluorescent nanosphere possessing reactive poly(ethylene glycol) tethered chains on the surface for zeptomole detection of protein in time-resolved fluorometric immunoassay","volume":"75","author":"Matsuya","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0580","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jconrel.2003.10.012","article-title":"Incorporation and release behavior of hydrophobic drug in functionalized poly(D,l-lactide)-block-poly(ethylene oxide) micelles","volume":"94","author":"Lee","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0585","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0927-7765(99)00063-6","article-title":"Stabilization and activation of pluronic micelles for tumor-targeted drug delivery","volume":"16","author":"Rapoport","year":"1999","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0590","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/bm401670t","article-title":"Light-responsive micelles of spiropyran initiated hyperbranched polyglycerol for smart drug delivery","volume":"15","author":"Son","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0595","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/adfm.201404484","article-title":"pH- and NIR light-responsive micelles with hyperthermia-triggered tumor penetration and cytoplasm drug release to reverse doxorubicin resistance in breast cancer","volume":"25","author":"Yu","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0600","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1016\/j.polymer.2012.06.024","article-title":"Reversibly light-responsive micelles constructed via a simple modification of hyperbranched polymers with chromophores","volume":"53","author":"Chen","year":"2012","journal-title":"Polymer"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0605","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1039\/c2cc16921e","article-title":"Visible light-responsive micelles formed from dialkoxyanthracene-containing block copolymers","volume":"48","author":"Yan","year":"2012","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0610","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpharm.2003.11.032","article-title":"Micellar solutions of triblock copolymer surfactants with pilocarpine","volume":"272","author":"Pepic","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0615","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/jop.2000.16.363","article-title":"Pharmacokinetics and anti-inflammatory activity in rabbits of a novel indomethacin ophthalmic solution","volume":"16","author":"Chetoni","year":"2000","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0620","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nano.2011.01.017","article-title":"Synergistic encapsulation of the anti-HIV agent efavirenz within mixed poloxamine\/poloxamer polymeric micelles","volume":"7","author":"Chiappetta","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0625","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.xphs.2016.03.006","article-title":"Alpha-lipoic acid in soluplus((R)) polymeric nanomicelles for ocular treatment of diabetes-associated corneal diseases","volume":"105","author":"Alvarez-Rivera","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0630","doi-asserted-by":"crossref","first-page":"11337","DOI":"10.1038\/srep11337","article-title":"Chitosan grafted methoxy poly(ethylene glycol)-poly(epsilon-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac","volume":"5","author":"Shi","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2015.11.059","article-title":"Pimecrolimus micelle exhibits excellent therapeutic effect for Keratoconjunctivitis Sicca","volume":"140","author":"Yingfang","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0640","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1208\/s12249-014-0100-4","article-title":"Novel dexamethasone-loaded nanomicelles for the intermediate and posterior segment uveitis","volume":"15","author":"Vaishya","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0645","doi-asserted-by":"crossref","first-page":"12968","DOI":"10.1038\/srep12968","article-title":"Nanomicelle formulation for topical delivery of cyclosporine A into the cornea: in vitro mechanism and in vivo permeation evaluation","volume":"5","author":"Guo","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0655","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1208\/s12249-014-0159-y","article-title":"Optimization of dexamethasone mixed nanomicellar formulation","volume":"15","author":"Cholkar","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0660","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1208\/s12249-014-0244-2","article-title":"Nanomicellar topical aqueous drop formulation of rapamycin for back-of-the-eye delivery","volume":"16","author":"Cholkar","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.4.3.1","article-title":"Topical, aqueous, clear cyclosporine formulation design for anterior and posterior ocular delivery","volume":"4","author":"Cholkar","year":"2015","journal-title":"Transl. Vis. Sci. Ttechnol."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0670","series-title":"Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca (Emerald), ClinicalTrials.gov","author":"SARL","year":"2016"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0675","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpb.2010.09.012","article-title":"Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability study","volume":"77","author":"Mondon","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0680","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1016\/j.biomaterials.2005.05.042","article-title":"Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution","volume":"26","author":"Aliabadi","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0685","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ejpb.2015.02.032","article-title":"Undefined role of mucus as a barrier in ocular drug delivery","volume":"96","author":"Ruponen","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0690","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/med.20155","article-title":"Carbohydrate recognition by boronolectins, small molecules, and lectins","volume":"30","author":"Jin","year":"2010","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0695","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/acs.biomac.6b00054","article-title":"Phenylboronic-acid-based polymeric micelles for mucoadhesive anterior segment ocular drug delivery","volume":"17","author":"Prosperi-Porta","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0700","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.1167\/iovs.13-13617","article-title":"In vivo imaging of a new indocyanine green micelle formulation in an animal model of laser-induced choroidal neovascularization","volume":"55","author":"Meyer","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0705","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1039\/c2nr30924f","article-title":"Diclofenac\/biodegradable polymer micelles for ocular applications","volume":"4","author":"Li","year":"2012","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0710","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/sj.gt.3301485","article-title":"In vivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles","volume":"8","author":"Liaw","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0715","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijpharm.2008.05.028","article-title":"Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels","volume":"361","author":"Kapoor","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0720","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1444-0938.2010.00553.x","article-title":"Drug delivery to the posterior segment of the eye through hydrogel contact lenses","volume":"94","author":"Schultz","year":"2011","journal-title":"Clin. Exp. Optom."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0725","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1166\/jnn.2016.11733","article-title":"Polymer micelles laden hydrogel contact lenses for ophthalmic drug delivery","volume":"16","author":"Hu","year":"2016","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0730","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1021\/acs.biomac.5b01526","article-title":"Fabrication of a micellar supramolecular hydrogel for ocular drug delivery","volume":"17","author":"Zhang","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0735","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1167\/iovs.11-8829","article-title":"A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation","volume":"53","author":"Di Tommaso","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0740","unstructured":"A.K. Mitra, S.L. Weiss, Topical aqueous nanomicellar, ophthalmic solutions and uses thereof, in, U.S. Patent 3\/975,175, 17 March 2015."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0745","unstructured":"A. Herrmann, V.J.W. De, M.S. Spitzer, S.O. Schnichels, Means and methods for ocular drug delivery, in, PCT\/NL2014\/050634, March 26, 2015."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0750","unstructured":"A.K. Mitra, P.R. Velagaleti, U.M. Grau, Topical drug delivery systems for ophthalmic use, in, PCT\/US2010\/033779, April 8, 2015."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0755","unstructured":"O.P. Perumal, S.K. Podaralla, R.K. Averineni, Polymer conjugated protein micelles, in, US 13\/404,392, April 15 2014."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0760","unstructured":"I.F. Uchegbu, A.G. Schatzlein, X. Hou, Polymeric micellar clusters and their uses in formulating drugs, in, PCT\/GB2007\/003016, June 25 2013."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0765","unstructured":"P. Moslemy, H. Wang, M. Patane, Ocular iontophoresis of charged micelles containing bioactive agents, in, PCT\/US2010\/050672, September 6 2012."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0770","unstructured":"S.K. Hahn, C.K. Joo, Y.K. Kim, S.K. Yoon, E.J. Oh, K.S. Kim, H. Kim, K. Park, J.A. Yang, J.S. Choi, Drug delivery system using hyaluronic acid-peptide conjugate micelle, in, US 13\/326,477, November 25 2014."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0775","unstructured":"A.K. Mitra, P.R. Velagaleti, U.M. Grau, Topical drug delivery systems for ophthalmic use, in, U.S. Patent 12\/774,6002010, April 28 2015."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0780","unstructured":"P. Moslemy, H. Wang, M. Patane, Ocular iontophoresis of charged micelles containing bioactive agents, in, U.S. Patent 13\/384,5182011, September 6 2012."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0785","unstructured":"Y.Y. Yang, S.Q. Liu, Micelles for drug delivery, in, PCT\/SG2006\/000188, January 10 2008"},{"key":"10.1016\/j.jconrel.2017.01.012_bb0790","unstructured":"I.F. Uchegbu, A.G. Schatzlein, X. Hou, Polymeric micellar clusters and their uses in formulating drugs, in, U.S. Patent 12\/376,8272008, June 25 2013."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0795","unstructured":"K. Kataoka, Y. Tamaki, A. Harada, F. Tasaka, Ophthalmic drug delivery system using polymer micelle, in, U.S. Patent 11\/251,1352006, May 25 2006."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0800","unstructured":"A. Harada, K. Kataoka, Y. Tamaki, F. Tasaka, Ophthalmic drug delivery system using polymer micell, in, EP20040724177, December 28 2005."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0805","unstructured":"K. Kataoka, Y. Tamaki, A. Harada, F. Tasaka, Ophthalmic drug delivery system using polymer micelle, in, CA 2520525, October 14 2004."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0810","unstructured":"A. Maitra, A.K. Gupta, D. Majumdar, S. Madan, Sustained release and long residing ophthalmic formulation and the process of preparing the same, in, U.S. Patent 09\/954,722, June 17 2003."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0815","unstructured":"S.E. Webber, T.J. Martin, pH dependent polymer micelles, in, U.S. Patent 08\/842,207, September 21 1999."},{"key":"10.1016\/j.jconrel.2017.01.012_bb0820","unstructured":"M.A. Galin, J.C. Salamone, S.C. Israel, Controlled release of miotic and mydriatic drugs in the anterior chamber, in, U.S. Patent 08\/815,215, June 16 1998."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917300172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917300172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T18:52:59Z","timestamp":1718995979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917300172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":163,"alternative-id":["S0168365917300172"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.01.012","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}